P&G Merger Talks Bring Pharmaceutical-As-Consumer-Brand Idea To Fore
This article was originally published in The Tan Sheet
Procter & Gamble's aborted merger discussions with Warner-Lambert and American Home Products may herald the next phase in the evolution of consumer-focused pharmaceutical marketing.
You may also be interested in...
Purchase of NutraMax's Optopics Laboratories ophthalmics division gives the Burlington, Mass.-based contract manufacturing and packaging firm an OTC product base that includes branded and private label eye drops, artificial tears, contact lens solution and cleansers, and industrial eye wash, along with eight Rx products. The deal closed Dec. 31 for an undisclosed sum; Optopics' FY 1998 sales totaled approximately $12 mil. Under the terms of the transaction, Miza acquired the division's 34,000 sq. ft. manufacturing and office facility in Fairton, N.J. The company anticipates no reductions in Optopics' 86-employee work force
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning